7-oh-cannabidiol (7-oh-cbd) and/or 7-oh-cannabidivarin (7-oh-cbdv) for use in the treatment of epilepsy
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- GW RES LTD
- Publication Date
- 2017-07-27
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] The present invention relates to the use of 7-hydroxy-cannabidol (7-OH-CBD) and / or 7-hydroxy-cannabidivarin (7-OH-CBDV) in the treatment of epilepsy.
[0002] Preferably the cannabinoid metabolites are isolated from plants to produce a highly purified extract or can be reproduced synthetically.BACKGROUND TO THE INVENTION
[0003] Epilepsy occurs in approximately 1% of the population worldwide, (Thurman et al., 2011) of which 70% are able to adequately control their symptoms with the available existing anti-epileptic drugs (AED). However, 30% of this patient group, (Eadie et al., 2012), are unable to obtain seizure freedom from the AED that are available and as such are termed as suffering from “treatment-resistant epilepsy” (TRE).
[0004] There are several different types of AED available to treat epilepsy, some of the most common AED defined by their mechanisms of action are described in the following tables:Examples of Narrow Spectrum AED
[0005] Narrow-spectrum AEDMechanismPhenytoinSodiu...